Studies have shown that GLP-1 receptor agonists provide better glycemic control and lower the risks of hypoglycemia compared to other anti-diabetes medications
Adjacent GHRH-class formats such as the Body Pharm Tesamorelin 32 Pen follow a different daily-dose convention and should not be substituted milligram-for-milligram
However, there are alternative medications to treat diabetes, such as insulin, Metformin, sulfonylureas, dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose co-transporter 2 (SGLT2) inhibitors, meglitinides, thiazolidinediones and alpha-glucosidase inhibitors
Pain is usually classified as postprandial, but it can also occur at night and interfere with sleep
GLP-1 Showdown: Inside The High Stakes War over Patients Novo Nordisk just declared legal war on Eli Lilly as the battle over GLP-1 patients intensifies